SCHEMBL13091046

SCHEMBL13091046

CCC(=O)Cc1ccc(C)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
SRC P12931 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
P2RX7 Q99572 3/20 0.40
PSMB5 P28074 2/20 0.40
PSMB8 P28062 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
NR3C1 P04150 1/20 0.38
PGR P06401 1/20 0.38
NR3C2 P08235 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14729157 0.90 NPC1 (0.46) NPC1RAB9ASMN1; SMN2SRCMEN1
SCHEMBL27959986 0.85 TAAR1 (0.46) NPC1RAB9ASMN1; SMN2SRCMEN1
SCHEMBL30300608 0.83 NPC1 (0.42) NPC1RAB9ASMN1; SMN2SRCMEN1
SCHEMBL3015011 0.83 SMN1; SMN2 (0.49) NPC1RAB9ASMN1; SMN2SRCMEN1
SCHEMBL22539808 0.81 P2RX7 (0.43) SMN1; SMN2SRCMEN1KMT2AP2RX7
SCHEMBL27515511 0.81 SRC (0.40) NPC1RAB9ASMN1; SMN2SRCMEN1
SCHEMBL11217315 0.80 NPSR1 (0.52) NPC1RAB9ASMN1; SMN2SRCMEN1
SCHEMBL1257788 0.80 SRC (0.62) NPC1RAB9ASMN1; SMN2SRCMEN1
SCHEMBL1257786 0.80 NPSR1 (0.45) NPC1RAB9ASMN1; SMN2SRCMEN1
SCHEMBL4050941 0.80 NPC1 (0.45) NPC1RAB9ASMN1; SMN2SRCMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010123139-A1 ARYLCARBOXAMIDE DERIVATIVE HAVING SULFAMOYL GROUP 持田製薬株式会社 (JP) 2010-10-28 WO disclosed